Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Nicholas Kitchin

Nicholas Kitchin

Senior Director in Pfizer’s Vaccine Clinical Research UK

ProfessorCharlesBangham

ProfessorCharlesBangham

Co-Director of the Institute of Infection UK

Kei Amemiya

Kei Amemiya

US Army Medical Research Institute of Infectious Diseases, USA

Asmaa McGowan

Asmaa McGowan

PhD, DelSiTech Ltd, Finland

Randa Hamadeh

Randa Hamadeh

Ministry of Public Health, Lebanon

Recommended Global Vaccines Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Vaccine Immunology 2024

Welcome Message

Greetings from the official website of the 6th World Congress on Vaccine and Immunology. This event is scheduled to occur in the beautiful city of Paris, France on November 28–29, 2024. This conference, which is dedicated to improving global health, provides an essential forum for the sharing of novel insights, ground-breaking studies, and creative approaches related to vaccines, vaccination, and immunization.

In order to improve public health through vaccination, we want to bring together researchers, medical experts, legislators, business executives, advocates, and students in a collaborative atmosphere that spans the knowledge gaps between study, policy, and practice.

Why to Attend

  • Embrace Innovation: Get involved at the cutting edge of vaccine development and research. Learn about the most recent developments, ground-breaking discoveries, and cutting-edge technology that are transforming the field of vaccination firsthand.
  • Global Networking: Connect with a varied group of people who share your interest for enhancing health outcomes through efficacious immunization tactics, ranging from seasoned professionals to up-and-coming talent. Create enduring relationships, consider joint ventures, and expand your network of professional contacts.
  • Knowledge Amplification: Attend stimulating keynote talks, take part in lively workshops, and attend sessions given by experts covering every aspect of vaccines, from development to effects on world health.
  • Impactful Insights: Gain a deeper comprehension of disease prevention, vaccine development, immunization regulations, and patient involvement. Bring home useful advice and best practices that will enable you to make noticeable progress at work.
  • Influential Experience: Take part in a two-day program that blends cultural immersion with academic stimulation. Take in the colorful and historic city of Paris while participating in thought-provoking conversations that could influence public health policy in the future.

Targeted Audience

The 6th World Congress on Vaccine and Immunology. Warmly invites professionals and enthusiasts from various domains, including but not limited to:

  • Researchers and Scientists
  • Physicians and Healthcare Practitioners
  • Immunologists and Virologists
  • Epidemiologists and Public Health Experts
  • Vaccination Program Managers and Administrators
  • Pharmacists and Pharmacy Professionals
  • Vaccine Manufacturers and Developers
  • Regulatory Authorities and Policy Makers
  • Industry Representatives and Innovators
  • Advocacy Groups and Non-profit Organizations
  • Students and Early-Career Professionals in Relevant Fields

Market Analysis

A biological preparation known as a vaccine offers active acquired protection to a specific illness. The most effective method of preventing infectious diseases is vaccination; broad immunity brought about by vaccination is largely responsible for the global eradication of variola and, consequently, for the global exclusion of illnesses like poliomyelitis, measles, and tetanus.

Market analysis of vaccines and immunology in 2024:

Global Health Concerns: The ongoing COVID-19 pandemic has brought vaccines and immunology to the forefront of global health discussions. Market analysis in 2024 would likely be heavily influenced by the trajectory of the pandemic, including vaccination rates, emergence of new variants, and public health responses.

Technological Advancements: Advances in vaccine technology, such as mRNA vaccines and novel delivery systems, may continue to shape the landscape of vaccine development and production. Market analysis would assess the impact of these advancements on vaccine availability, efficacy, and distribution.

Government Policies: Government policies and regulations related to vaccination, immunization programs, and public health funding will play a significant role in shaping the market dynamics. Changes in government priorities or regulations could impact vaccine research, manufacturing, and distribution.

Disease Outbreaks: The emergence of new infectious diseases or reemergence of existing ones can influence the demand for vaccines and immunological products. Market analysis would evaluate the response to disease outbreaks and the potential market opportunities for vaccines targeting these diseases.

Global Immunization Initiatives: International efforts to improve immunization coverage, such as through initiatives by organizations like the World Health Organization (WHO) and Gavi, the Vaccine Alliance, will impact the market analysis. Evaluating the effectiveness of these initiatives and their implications for vaccine markets will be important.

Research and Development: Ongoing research in immunology, including efforts to develop vaccines for diseases such as HIV/AIDS, malaria, tuberculosis, and cancer, will contribute to the market analysis. Assessing the progress of research pipelines and the potential commercialization of new vaccines will be key considerations.

Public Perception and Vaccine Hesitancy: Public attitudes towards vaccination, vaccine hesitancy, and misinformation campaigns can influence vaccine uptake and market dynamics. Market analysis may include assessments of public perception, communication strategies, and efforts to address vaccine hesitancy.

 

To Collaborate Scientific Professionals around the World

Conference Date November 28-29, 2024

Speaker Opportunity

Supported By

Journal of Immunobiology Journal of Immunological Techniques & Infectious Diseases Journal of Clinical and Cellular Immunology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by